• 23 Hits
  • 検索条件 : 絞込み (MeSH = Protein Kinase Inhibitors / therapeutic use*)
生物種 リソース名 タイトル
ヒト・動物細胞 K562 Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia.
ヒト・動物細胞 A549 , RERF-LC-AI(RCB0444) , RERF-LC-KJ(RCB1313) Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad.
ヒト・動物細胞 Ba/F3(RCB0805) , PC-9(RCB4455) TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations.
ヒト・動物細胞 MKN45(RCB1001) 5‑FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53‑mutated colon cancer cells.
ヒト・動物細胞 HGC-27(RCB0500) Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer.
ヒト・動物細胞 HS-Sch-2(RCB2230) , YST-1(RCB2136) , HS-PSS(RCB2362) Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
ヒト・動物細胞 HuH-6(RCB1367) The Collagen Gel Droplet-embedded Culture Drug Sensitivity Test in Relapsed Hepatoblastoma.
ヒト・動物細胞 MRMT-1(RCB2860) Effects of Src-kinase inhibition in cancer-induced bone pain.
ヒト・動物細胞 LC-2/ad(RCB0440) Enhanced antitumor effect of alectinib in combination with cyclin-dependent kinase 4/6 inhibitor against RET-fusion-positive non-small cell lung cancer cells.
ヒト・動物細胞 HuH-7 Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
ヒト・動物細胞 TE-6(RCB1950) , TE-8(RCB2098) , TE-11(RCB2100) , TE-14(RCB2101) , TE-15(RCB1951) Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma.
ヒト・動物細胞 PC-9(RCB4455) The Significance of MMP-1 in EGFR-TKI-Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting.
ヒト・動物細胞 HS-SY-II(RCB2231) Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.
ヒト・動物細胞 MC3T3-E1(RCB1126) Therapeutic potential of compound K as an IKK inhibitor with implications for osteoarthritis prevention: an in silico and in vitro study.
ヒト・動物細胞 9-15C(RCB2323) PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.
ヒト・動物細胞 TKKK(RCB1907) Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
ヒト・動物細胞 PC-9(RCB4455) Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations.
ヒト・動物細胞 OCUB-F(RCB0882) mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer.
ヒト・動物細胞 Fasudil suppresses fibrosarcoma growth by stimulating secretion of the chemokine CXCL14/BRAK.
ヒト・動物細胞 HuH-7 Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.